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Abstract
Background: Asthma exacerbations are caused by a variety of  risk factors. Reducing exposure to these risk factors improves 
the control of  asthma and reduces medication needs. Knowledge of  the particular risk factors is essential in formulating 
controlling and treatment protocols. This study set out to determine the risk factors for asthma exacerbations in patients 
presenting to the emergency unit of  Mulago Hospital.
Methods: An unmatched case-control study involving 43 cases and 43 controls was conducted from November 2011 through 
February 2012. Asthma patients with exacerbations presenting to Mulago hospital’s emergency unit were chosen as cases. 
The controls were asthma patients recruited from the hospital’s outpatient department who had not had an exacerbation 
in the past 7 days. The study variables were age, sex, level of  education, adherence to treatment, exercise, upper respiratory 
tract infections, household pets, smoking, strong emotions, exposure to in house wood or charcoal burning, weather, use of  
corticosteroids, beta-blockers and non-steroidal anti-inflammatory drugs. Univariate and multivariate statistical analysis was 
done using SPSS version 16 to identify independent risk factors for exacerbations.
Results: Lack of  corticosteroid use (OR =22.109; 95% Confidence interval 6.952 to 70.315; p<0.001) and presence of  
upper respiratory tract infections (OR 4.516; CI 1.258-16.213; p=0.018) were significantly associated with exacerbations.
Conclusion: Lack of  corticosteroid use and upper respiratory tract infections are associated with exacerbations in asthma 
patients presenting to the Emergency unit of  Mulago Hospital
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Introduction
Asthma is a worldwide problem with an estimated 300 
million people currently affected , 38.9 million from 
sub-Saharan Africa and a global prevalence ranging 
from 1% to 18% (1). The global prevalence of  asthma 
is continuing to rise with increases in asthma symptom 
prevalence in Africa (2). 
Asthma exacerbations can be  associated with a variety 
of  risk factors. Notably asthma exacerbations are 
associated with  exposure to irritants such as cigarette 
smoke exposure and diesel exhaust fumes (3, 4), inhalant 
allergens such as house dust mites (5),  drugs known to 
worsen asthma (6), poor adherence/non-compliance to 
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  exercise, respiratory infections (8) and strong emotions 
(9)  to date we are unware of  studies investigating risk 
factors of  asthma exacerbations in Mulago Hospital 
in particular and Uganda in general. A case control 
study in Canada found symptomatic colds as the most 
common trigger of  asthma exacerbations in the winter 
and spring, while a transient increase in dust exposure 
was also identified as a significant trigger (10). However, 
this is a different environment compared to Uganda in 
terms of  weather and affluence.
Noncompliance to treatment was found as a strong 
predictor of  exacerbations in adult patients in a South 
African hospital (11). 
A study in a university hospital serving developing 
communities in the Western Cape province,  South 
Africa found the risk factors for severe life threatening 
asthma to be rural residence, poverty and lack of  use of  
inhaled corticosteroids (12).
The main risk factors for wheeze in urban children 
in Ethiopia are environmental tobacco smoke, use of  
kerosene and a longer duration of  breastfeeding (13). 
No study looking at reasons for exacerbations in asthma 
patients has been done in Mulago Hospital. Knowledge 
of  the particular risk factors precipitating asthma 
exacerbations in our patients is essential in formulating 
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controlling and treatment protocols . The objective 
of  this study was to determine the risk factors for 




This was an unmatched case-control study to investigate 
the risk factors causing exacerbations in patients with 
asthma attending the Emergency Unit of  Mulago 
Hospital. 
The study was carried out in the Emergency Unit and 
the Medical Outpatient Department Chest Clinic of  
Mulago National referral Hospital. The Emergency 
unit is the portal for all emergencies in the hospital. 
The medical wing of  the emergency unit receives about 
80 patients per day.   The majority of  these are self- 
referred patients from the surrounding communities. 
Asthma exacerbations constitute 2.5% of  emergency 
visits in Mulago Hospital. Sixty five percent of  all asthma 
visits in Mulago Hospital are due to exacerbations More 
than 90% of  these patients are treated as outpatients 
with some being frequently readmitted and having no 
clear documentation of  the risk factors triggering these 
exacerbations (14).
The chest clinic is a specialist outpatient clinic that 
provides care to patients with respiratory diseases. 
About 800 patients are seen in this clinic annually and 
16.9% of  them are patients with asthma. The chest clinic 
operates for one day in a week. The hospital doubles as 
the teaching hospital for Makerere University College 
of  Health Sciences. (14)
Study eligibility:  Patients were included in this study 
if  they were 13 years and older and had asthma. In this 
study, a patient with asthma was defined as a person 
with a history of  recurrent episodes of  wheezing and 
cough that is often reversible either spontaneously or 
with treatment and any one of  the following: Personal/ 
family history of  asthma and a physician/doctor 
diagnosis of  asthma 
The cases were asthma patients who had developed 
an acute asthma exacerbation. An acute asthma 
exacerbation was defined in this study as having all four 
of  the following: 
1. An emergency room visit because of  asthma
2.  Forced Expiratory Volume in one second (FEV1) 
of  less than 80% of  the predicted value for   age, sex 
and height.
3. Reduced ratio of  FEV1 to Forced Vital Capacity 
(FEV1/FVC) of  less than 70%.
4. Reversibility demonstrated by an increase in FEV1 
of  12% or 200mls after the administration of  a short 
acting bronchodilator (salbutamol).
The controls were asthma patients who had had no 
exacerbations requiring emergency visits during the 
preceding 7 days but with history of  wheezing in the 
past twelve months.
Patients with any history of  pulmonary embolism, 
active pulmonary TB, chronic obstructive pulmonary 
disease, known congestive heart failure, known 
mechanical obstruction (e.g. tumor) were excluded. 
Prior participation in the study constituted an exclusion 
criterion. A record of  the study participants was kept 
by the principal investigator and research assistants. 
Any potential participant’s particulars were verified to 
ensure that they had not participated in the study. 
Cases and controls were recruited from the 
emergency unit and the medical outpatient chest clinic 
respectively.
Study Variables and definitions: 
The study variables were age, sex, level of  formal 
education, occupation, non-adherence to asthma 
medication use of  corticosteroids, exercise/sport, upper 
respiratory tract infections, household pets, smoking 
(active and passive), stoves (exposure to in house wood 
or charcoal burning) , weather and use of  drugs known 
to worsen asthma.
Non-adherence to asthma medication was  measured 
by the 4-item self-report scale developed by Morisky 
et al (15). Exercise was considered a risk factor if  the 
participant was involved in any formal or informal 
sports activities including walking distances of  at 
least 1km. Upper respiratory tract infections (URTI) 
were seen as a risk factor when at least three of  the 
following five components are marked positive: sore 
throat, fever, runny/blocked nose, muscle aches and 
exposure to other people with a cold. The Household 
pets considered were cats or birds in the house or in the 
direct work place.
The strong emotions considered were anger, excitement 
and anxiety. Anger was seen as a risk factor when a 
participant had any loss of  temper during the exposure 
assessment period. Excitement was seen as a risk factor 
when a participant was extremely excited or happy 
about something e.g. sports, finances, or relationships. 
Anxiety was seen as a risk factor when a participant was 
anxious for reasons related to death of  a relative, work 
etc.
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Weather was considered as a risk factor for all participants 
who experienced rainy weather conditions during their 
exposure assessment period.
The drugs known to worsen asthma are any orally 
ingested, rectally inserted or injected Non-steroidal 
anti- inflammatory drug and any Any beta blocker-
containing medication.
Sample size calculation: 
The following formulae by James Schlesselman (1974) 
were used to calculate the sample size.
              n =       (1+1/c)pq(Zα +Zβ)2      
                                   (P1- P0)
2
             P1=               PoR         .                             p = 
(P1+cPo)  
                           [1+Po(R-1)] 
(1+C)
Where: 
C= number of  controls per case which is 1
R (Relative Risk) – estimated relative risk (odds ratio) 
= 2.18 Derived from a South African study of  asthma 
risk factors which found non-adherence to treatment as 
a risk factor for asthma exacerbation.
Po = Expected proportion of  controls (asthma patients 
without exacerbations) = 0.5 (since we do not know the 
figures for our setting)
Calculated P1 = 0.69
Calculated p = 0.59
n = Number of  cases i.e. patients with asthma 
exacerbations
 Zα = 1.96 for α of  0.05 (where α is the significance) 
Zβ = 0.84 for β of  0.2 (where 1-β is the power)
Substitution of  the above values into the formula gives
Cases – 38
Assuming 10% non-responders (NR) will increase the 
number of  cases to 43 and the controls to 43 giving a 
total sample size of  86.
Measurements and data Collection:
Patients with asthma who met the inclusion criteria 
(both cases and controls) were requested to participate 
in the study.  Their demographic and clinical data 
were recorded.  The procedure and purpose of  doing 
spirometry was explained to the study patients. With the 
patients seated, spirometry was done using an electronic 
spirometer (NDD EasyOne, Massachusetts, USA) 
and the FEV1 and FEV1/FVC ratio were measured. 
Emphasis was made about the essential elements of  the 
test like filling lungs completely, sealing lips around the 
spirette so that there are no leaks, taking care not to 
block its opening with teeth or tongue, blowing out as 
hard and fast as possible and continuing to blow out 
until the lungs are completely empty.  Three acceptable 
readings were considered.
For the cases (patients in asthma exacerbation), 5 puffs 
of  salbutamol metered dose inhaler were administered 
using a spacer.  Spirometry was repeated after 15 minutes 
to demonstrate reversibility (increase in FEV1 of  12% 
or 200mls).  Patient care was by the attending physicians. 
In summary patients received parenteral steroid 
(intravenous hydrocortisone or oral prednisolone), 
inhalational bronchodilators by either nebulization 
or frequent administration of  bronchodilators by the 
metered dose inhaler every 15 minutes and oxygen 
depending on the severity of  the exacerbation. Patients 
were monitored in the emergency room until stable 
before transfer to the admitting wards.A structured 
questionnaire was used as a basis for interviewing the 
participants. Information obtained about the risk factors 
included adherence to treatment, upper respiratory 
tract infections, exercise, smoking, in-house charcoal 
fires, drugs known to worsen asthma (like beta blockers, 
NSAIDS), use of  corticosteroids, strong emotions and 
exposure to household pets. Exposure to the risk factors 
was noted for the previous week (7 days) in both cases 
and controls.
Data management and analysis:
Data was entered into Epidata version 3.1 and exported 
to SPSS version 16.0 for analysis. Continuous data were 
summarized into means, while categorical variables 
were summarized into percentages and proportions. 
A p-value of  less than 0.05 was considered significant. 
We compared baseline characteristics of  the cases and 
controls using Student’s t test for when continuous 
variable and chi-square test when they were proportions. 
Risk factors for asthma exacerbations were evaluated 
by logistic regression in univariate and multivariate 
analyses. Asthma exacerbation was the dependent 
variable. Following univariate analysis, factors that had 
association with p-value less 0.20 were entered into a 
multivariable logistic regression model to assess for 
independence of  association. 
Ethics: 
Approval was obtained from the department of  
Medicine, Mulago Hospital and the Research and Ethics 
Committee of  Makerere University College of  Health 
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Sciences. Informed consent/assent was obtained from 
all patients. Confidentiality was ensured throughout the 
study.
Results
During the study period (November 2011 through 
February 2012) 49 patients with suspected asthma 
exacerbation were approached and 43 were recruited. 
Figure 1: patient flow diagram





2 could not perform spirometry, 2 
had no reversibility on spirometry, 1 
had normal spirometry and 1 patient 
declined to participate
43 Controls43 Cases 
with Asthma 
Exacerbation
   1:1
 
 
Of  the 6 who were excluded, 2 could not perform 
spirometry, 2 had no reversibility on spirometry after 
administration of  inhaled salbutamol, 1 had normal 
spirometry and 1 patient declined to participate in the 
study. For each of  the 43 cases 1 control was selected in 
the chest clinic. A total of  43 controls were selected.
The demographic characteristics of  the study patients 
are shown in Table1.








Male 15 (34.9) 19 (44.2) 34(39.5)
Female 28 (65.1) 24 (55.8) 52(60.5)
Age
Mean age 32.9 39.0 36.0
Std deviation 14.3 18.5 16.7
Employment
Unemployed 7 (16.3) 12 (27.9) 19(22.1)
Self  employed 12 (27.9) 9 (20.9) 21(24.4)
Civil servant 2 (4.7) 4 (9.3) 6(7.0)
Peasant 4 (9.3) 5 (11.6) 9(10.5)
Others 18 (41.9) 13 (30.2) 31(36.0)
Education level
No formal education 1 (2.3) 2 (4.7) 3(3.5)
Primary education 20 (46.5) 15 (34.9) 35(40.7)
O’level 17 (39.5) 17 (39.5) 34(39.5)
A’level 0 3 (7.3) 3(3.5)
Tertiary 5 (11.6) 6 (14.0) 11(12.8)
Marital status
Single 16 (37.2) 13 (30.2) 29(33.7)
Married 16 (37.2) 21 (48.8) 37(43.0)
Separated 7 (16.3) 5 (11.6) 12(14.0)
Widowed 4 (9.3) 4 (9.3) 8(9.3)
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Among the 43 cases the mean age was 32.86 years 
(standard deviation (SD) 14.3) whereas among the 43 
controls selected the mean age was 39 (SD 18.48). The 
majority of  the study participants were in the 12-39 year 
age group (cases 67%, controls 51.2%)
The clinical characteristics of  the study patients are 
shown in Table 2.





Wheezing after exercise 39(90.7) 38(88.4)
Limitation of  physical activity by asthma 37(86) 33(76.7)
Troublesome cough at night 39 (90.7) 36(87.7)
Pre-bronchodilator FEV1
≥80% (Normal) 0 19 (44.2)
60-79% (Mild Obstruction) 5 (11.6) 11 (25.6)
40-59% (Mod. Obstruction) 14 (32.6) 7 (16.3)
<40% (Severe Obstruction) 24 (55.8) 6 (14.0)
Mean BMI ± SD 22.6 ± 6.0 22.1 ± 4.8
Mean number of  attacks in the past 7 days ± SD 5.2 ± 6.1 2.1 ± 2.8
Mean number of  nights with troublesome cough in 
the past 4 weeks ± SD 
14.5 ± 10.9 7.5 ± 7.2
Mean Pre-bronchodilator FEV1± SD 38.5 ± 16.2 69.3 ± 23.2
The cases had five attacks of  wheezing in the past seven 
days while the controls reported two attacks. Of  the 
cases, 39 (90.7%) reported troublesome cough at night 
over the past one month with a mean of  14.51 nights 
(SD 10.85) with troublesome cough. Thirty six (87.7%) 
controls reported troublesome cough at night over the 
past one month with a mean of  7.51(SD 7.23) nights of  
troublesome cough.
Risk factors for asthma exacerbations
Patients with asthma exacerbations were younger (Mean 
age 32.86years SD 14.334) than the controls (Mean age 
39.0 years SD 18.480) and the difference was statistically 
significant (p= 0.044). Lack of  corticosteroid use in 
the past 7 day was strongly associated with asthma 
exacerbations (OR 22.101, CI 6.952-70.315, P<0.001). 
Thirty two of  the patients with asthma exacerbation 
(74.4%) had not used corticosteroids (oral or inhaled) 
compared to 5 of  the controls (11.6%). We also found 
that presence of  upper respiratory tract infections 
showed a trend towards significance as a risk factor 
for exacerbations on bivariate analysis (OR 2.1332 CI 
0.899-5.052, P=0.08) (table 3). 









Age(Mean±SD) 32.9±14.3 39.0±18.48 0.044
Education 0.354
No formal education 1(2.3) 2(4.7)
Primary education 20(46.5) 15 (34.9) 3.286 0.025-424.749 0.632
O’level 17 (39.5) 17 (39.5) 0.894 0.007-116.252 0.964
A’level 0 3 (7.3) 0.000 0.000 0.999
Tertiary 5 (11.6) 6 (14.0) 4.986 0.026-958.217 0.549
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URTI yes 24 (55.8) 16 (37.2) 2.132 0.899-5.053 0.086
No 19(44.2) 27(62.8)
Living with pets Yes 17 (39.5) 15 (34.9) 0.819 0.341-1.967 0.656
No 26(60.5) 28(65.1)
Smoking
Active Smoking Yes 4 (9.3) 2 (4.7) 0.476 0.082-2.745 0.406
No 39(90.7) 41(95.3)
Passive smoking Yes 17 (39.5) 9(20.9) 0.405 0.156-1.053 0.064
No 26(60.5) 34(79.1)
Strong emotions
Anger Yes 16 (37.2) 11 (25.6) 0.580 0.231-1.460 0.247
No 27(62.8) 32(74.4)
Excitement Yes 11 (25.6) 4 (9.3) 0.298 0.087-1.027 0.055
No 32(74.4) 39(90.7)
Anxiety Yes 7 (16.3) 5 (11.6) 0.677 0.197-2.326 0.535
No 36(83.7) 38(88.4)
In-house wood burning 
or charcoal stoves
Yes 32 (74.4) 33 (76.7) 0.882 0.329-2.360 0.802
No 11(25.6) 10(23.3)




Rainy Weather Yes 29 (67.4) 30 (69.8) 0.898 0.361-2.233 0.816
No 14(32.6) 13(69.8)
Exercise Yes 14 (32.6) 10 (23.3) 1.593 0.615-4.130 0.338
No 29(67.4) 33(76.7)
NSAIDS Yes 5 (10.5) 4 (9.3) 1.283 0.320-5.143 0.725
No 38(88.4) 39(90.7)
Beta-blockers Yes 0 2 (4.7) 0.000 0.000 0.999
No 43(100) 41(95.3)
Used corticosteroids Yes 11(25.6) 38 (88.4) 0.019 0.011-0.144 <0.001
No 32(74.4) 5(11.6) 22.109 6.952-70.315 <0.001
Used  inhaled 
corticosteroids
Yes 4(9.3) 22(51.2)
No 39(90.7) 21(48.8) 10.214 3.107-33.579 <0.001
Used oral corticosteroids Yes 9(20.9) 32(74.4)
No 32(79.1) 11(25.6) 10.990 4.025-30.009 <0.001
Adherent  to medication Yes 17(39.5) 19(44.2) 0.826 0.350-1.948 0.662
No 26(60.5) 24(55.8)
As can be seen in table 3, sex, level of  education, non-
adherence to medication, exercise/sport, household 
pets, smoking, strong emotions, exposure to in house 
wood or charcoal burning, rainy weather, non-steroidal 
anti- inflammatory drugs and beta blockers were not 
found to be statistically significant risk factors.
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At multivariate level analysis the only factors found to be 
independently associated with asthma exacerbation were 
lack of  corticosteroid use in the past 7 days (P<0.001) 
and upper respiratory tract infections (P=0.018) (table 
4)
Table 4: Factors associated with asthma exacerbation at multivariate analysis
Variable Odds Ratio CI P Value
Age 0.755 0.523-1.090 0.710
URTI 4.516 1.258-16.213 0.018
Used Corticosteroids 0.031 0.08-0.118 <0.001
Discussion
This study has established that lack of  use of  
corticosteroids (oral or inhaled) in the past 7 days is 
associated with asthma exacerbations in Mulago hospital. 
Inhaled corticosteroids (ICSs) are essential medicines 
for all but the mildest asthma. Corticosteroids reduce the 
production of  pro-inflammatory cytokines, particularly 
the Th2 cytokines IL-4, 5 and 13; airway spasmogens 
like leukotriene LTB4 and LTC4 and thromboxane; and 
the influx and survival of  inflammatory cells specifically 
eosinophils, lymphocytes, macrophages and mast cells 
(16, 17).  The START trial (18), the largest trial of  ICSs 
to date, which established the role of  ICSs in reducing 
exacerbations and improving lung function showed 
nearly a 50% reduction in time to first exacerbations 
in the treatment arm with a significantly reduced (2 
vs 0.4%) number of  severe/life threatening events 
compared to placebo.
The reasons for failure to use ICSs were not established 
in this study but could be due to cost, lack of  awareness 
about ICSs among health care providers or patient 
ignorance. Watson et al in a study to assess the therapeutic 
aspects of  published international asthma management 
guidelines in developing countries found that many 
asthma patients in developing countries are not receiving 
adequate treatment because the required drugs are not 
available in their area or are prohibitively expensive (19). 
Regular use of  steroid inhalers was correctly prescribed 
by only 1.8% surveyed doctors in an Indian study (20). 
A survey of  Nigerian doctors showed that that inhaled 
corticosteroids were infrequently prescribed (21). A 
retrospective chart review by Kirenga et al found that 
only 2.4% of  asthma patients received a prescription of  
an inhaled corticosteroid from the emergency unit of  
Mulago Hospital (14). More than half  of  the controls 
in this study were on inhaled corticosteroids. This is 
higher than that found in an earlier study by Kirenga 
and others where 24.2% of  asthma patients in the chest 
clinic were on inhaled corticosteroids (14).
Upper respiratory tract infections were significant 
as a risk factor for exacerbations in this study. This 
is consistent with a study by Nicholson  et al which 
found that URTI/Viral infections are the cause of  
an exacerbation in about 65% of  adults  with asthma 
(22).  A study in Nigeria of  microbial inciters of  asthma 
exacerbation in urban children identified viral agents 
(RSV, Parainfluenza and influenza viruses) in 53% 
of  patients and bacterial isolates in only 3.5% (throat 
swabs). This emphasizes the importance of  viral upper 
respiratory tract infections in asthma exacerbation 
(23). 
Exercise/sport, household pets, smoking, strong 
emotions, exposure to in house wood or charcoal 
burning, rainy weather, NSAIDS and beta blockers 
were not found to be statistically significant risk factors 
for asthma exacerbation in this study. This is similar to 
findings by Geiser and colleagues in a South African 
hospital (11).
A study by Emerman et al found no relationship 
between asthma relapse and cigarette smoking or pets 
in the home (24). None of  the patients with asthma 
exacerbation in this study had received a beta blocker in 
the preceding week. This is likely due to awareness of  
the adverse effects. 
Although not found to be a risk factor, non-adherence 
to medication was high in both the cases and controls 
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(60.5% vs. 55.8%). Gamble and others found poor 
adherence to be as high as 88% in patients with severe 
asthma (25).
Majority of  study participants reported limitation of  
physical activity by asthma, attacks of  wheeze in the 
past 7 days and troublesome cough at night in the past 
4 weeks. This shows that most of  the asthma patients 
studied had poorly controlled asthma.
This study had limitations. It may not be generalized 
beyond the study population, as it involves patients 
at a single center. The diagnosis of  respiratory tract 
infections was clinical.  This being a case control study, 
recall bias may be a limitation. Only patients with an 
obstructive picture on spirometry were included as 
cases. Age and gender were not controlled for in the 
analysis.
Conclussion
Lack of  corticosteroid use (oral or inhaled) and 
upper respiratory tract infections are risk factors for 
exacerbations in asthma patients presenting to the 
emergency unit of  Mulago Hospital. The need to use 
inhaled corticosteroids as controller therapy for patients 
with asthma should be emphasized among patients and 
health care providers
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